Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,039 | 102,382 | 57,883 | 74,910 | 78,190 |
| Marketable Securities | 120,964 | 83,139 | 26,639 | 10,132 | 16,921 |
| Receivables | 1,359 | N/A | N/A | N/A | N/A |
| Inventories | 1,231 | N/A | N/A | N/A | N/A |
| TOTAL | $174,649 | $190,434 | $90,305 | $91,786 | $101,096 |
| Non-Current Assets | |||||
| PPE Net | 2,205 | 2,016 | 1,964 | 1,874 | 2,011 |
| Investments And Advances | 0 | 1,007 | 11,614 | 28,316 | 32,021 |
| Intangibles | 59,561 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 441 | 456 | 470 | 482 | 493 |
| TOTAL | $62,207 | $3,479 | $14,048 | $30,672 | $34,525 |
| Total Assets | $236,856 | $193,913 | $104,353 | $122,458 | $135,621 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,949 | 3,791 | 5,658 | 7,238 | 3,546 |
| Accrued Expenses | 20,755 | 13,552 | 12,217 | 12,434 | 13,646 |
| TOTAL | $90,390 | $25,118 | $25,154 | $27,046 | $22,791 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,471 | 23,298 | N/A | N/A | N/A |
| Deferred Revenues | 17,686 | 7,775 | 7,279 | 7,374 | 5,599 |
| Other Non-Current Liabilities | 439 | 480 | 518 | 555 | 590 |
| TOTAL | $24,617 | $24,026 | $518 | $1,206 | $2,096 |
| Total Liabilities | $115,007 | $49,144 | $25,672 | $28,252 | $24,887 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,781 | 87,191 | 81,550 | 64,040 | 63,375 |
| Common Shares | 9 | 9 | 7 | 6 | 6 |
| Retained earnings | -405,639 | -372,362 | -343,729 | -314,042 | -292,074 |
| Other shareholders' equity | -647 | -886 | -841 | -714 | -139 |
| TOTAL | $121,849 | $144,769 | $78,681 | $94,206 | $110,734 |
| Total Liabilities And Equity | $236,856 | $193,913 | $104,353 | $122,458 | $135,621 |